PITT Study: Blood Collection SOP (1350)
Citation: Fogarty International Center & NIH R21TW011157. 2018. Maia Kipiani, MD., Matthew J. Magee, PhD, MPH., Russell R. Kempker, MD, MS., Sara C. Auld, MD, MS., Hardy Kornfeld, MD., Sergo Vashakidze, MD., Argita D. Salindri, PhD, MPH. National Center for Tuberculosis and Lung Diseases, Emory University, University of Massachusetts.
Study Description: This study follows a cohort of participants from the country of Georgia who successfully completed pulmonary tuberculosis treatment. The primary goal is to determine if post-tuberculosis trajectories in pulmonary impairment are different in participants who received treatment for drug-sensitive compared to treatment for drug-resistant tuberculosis. This study also explores whether biomarkers of pulmonary inflammation are associated with post-tuberculosis sequalae.
Please complete the form below to download this resource
Thank you to our contributing institutions





















